Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Keith R. Gollust currently holds 1,539,169 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keith R. Gollust has been a net buyer of SNTA stock. They have purchased $6.2M and sold $741.6K worth of shares.
Keith R. Gollust's most recent insider trade was on Dec 14, 2015, when they sold 300,000 shares at $0.32 per share.
Keith R. Gollust serves as Executive at SYNTA PHARMACEUTICALS CORP (SNTA). They have executed 67 insider transactions totaling $6.9M over their tenure at the company.
Keith R. Gollust holds the position of Executive at SYNTA PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Keith R. Gollust has shown a buying trading pattern, with $6.2M in total purchases and $741.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Keith R. Gollust was on Jul 25, 2012, when they purchased $5.0M worth of SNTA shares. This transaction involved 770,416 shares at $6.49 per share.
Keith R. Gollust currently owns 1,539,169 shares of SYNTA PHARMACEUTICALS CORP (SNTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Keith R. Gollust's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Keith R. Gollust has 67 Form 4 filings on record as an insider at SYNTA PHARMACEUTICALS CORP.
Set alerts for Keith R. Gollust and 40,000+ other insiders.